aminocaproic acid has been researched along with Kidney Failure, Chronic in 3 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fish, SS | 1 |
Pancorbo, S | 1 |
Berkseth, R | 1 |
Perazella, MA | 1 |
Biswas, P | 1 |
Nzerue, CM | 1 |
Falana, B | 1 |
3 other studies available for aminocaproic acid and Kidney Failure, Chronic
Article | Year |
---|---|
Pharmacokinetics of epsilon-aminocaproic acid during peritoneal dialysis.
Topics: Aminocaproates; Aminocaproic Acid; Female; Fibrinolysis; Half-Life; Humans; Kidney Failure, Chronic; | 1981 |
Acute hyperkalemia associated with intravenous epsilon-aminocaproic acid therapy.
Topics: Acute Disease; Aged; Aminocaproic Acid; Arginine; Blood Loss, Surgical; Coronary Artery Bypass; Huma | 1999 |
Refractory hyperkalaemia associated with use of epsilon-aminocaproic acid during coronary bypass in a dialysis patient.
Topics: Aminocaproic Acid; Calcium Gluconate; Cardiopulmonary Bypass; Coronary Artery Bypass; Electrocardiog | 2002 |